
GLP-1 рецептор агонист 8 is a мощный агонист of GLP-1 R. GLP-1 рецептор агонист 8 has the potential for the research of diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) (extracted from patent WO2019239319A1, compound 17).
GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R. GLP-1 receptor agonist 8 has the potential for the research of diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) (extracted from patent WO2019239319A1, compound 17).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.